Evaluation of BH4 Responsiveness in Our PKU Patients
NCT07255599
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Phenylketonuria (PKU)
Interventions
DRUG:
Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)
Sponsor
Sohag University